Search

Your search keyword '"Ashraf Z"' showing total 51 results

Search Constraints

Start Over You searched for: Author "Ashraf Z" Remove constraint Author: "Ashraf Z" Publisher elsevier bv Remove constraint Publisher: elsevier bv
51 results on '"Ashraf Z"'

Search Results

1. Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts)

2. Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era

4. Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial

5. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

8. Therapy-related B-lymphoblastic leukemia after multiple myeloma

9. OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)

10. P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma

11. P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin

12. Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM)

13. MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM)

14. Eosinophilic Myocarditis in a Patient With Multiple Myeloma

15. P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma

19. OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)

20. Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM)

22. MM-350: Daratumumab (DARA) + Lenalidomide/Bortezomib/Dexamethasone (RVd) in African American/Black Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of GRIFFIN

25. A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

26. Mobilized side and tip resistances of piles in clay

27. Evaluating sediment yield at King Talal Reservoir from landslides along Irbid–Amman Highway

28. Synergistic Effects of Superbasic Catalysts on the Selective Formation of Acrylonitrile via Oxidative Methylation of Acetonitrile with Methane

29. Oxidative Methylation of Toluene with Methane over Superbasic Catalysts: A Selective Route to Styrene and Ethylbenzene through Alternative Feedstocks

30. A comparative study of oxidative methylation of toluene with methane to styrene and ethylbenzene over bi-alkali-promoted MgO, CaO, SrO or BaO

31. Oxidative Coupling of Methane over Alkali-Metal-Compound-Promoted Zirconia Catalysts

32. Oxidative coupling of methane over alkali metal chloride promoted zirconia Effect of the preparation method

34. Investigation of oxidative coupling of methane over bismuth oxychloride, samarium chloride, or manganese chloride supported on lithium carbonate-magnesia systems

35. A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia

40. A242 Vorinostat and Bortezomib in Relapsed/Refractory MM

44. Noninvasive Ventilation in the Weaning of Patients with Acute-on-Chronic Respiratory Failure due to COPD

46. Investigation of Kölbel—Engelhardt Synthesis over Iron-Based Catalysts

47. Polymetallic catalysts derived from intermetallic hydrides

48. Insulin secretion and body composition in obesity

Catalog

Books, media, physical & digital resources